The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Global burden of lung cancer in 2022 and projections to 2050: Incidence and mortality estimates from GLOBOCAN
Open accessAbstract
BACKGROUND: Lung cancer continues to pose a serious global public health challenge. Timely evidence on the global epidemiological profile of the disease is crucial to facilitate the implementation to lung cancer control efforts. This study provides updated global estimates for lung cancer incidence and mortality in 2022, along with projections for new cases and deaths up to 2050. METHODS: In the population-based study, we extracted data about lung cancer new cases and deaths from GLOBOCAN 2022 database across 185 countries or territories. We analyzed age-standardized rates by sex, country, region, and human development index (HDI). Projected new cases and deaths for 2050 were estimated using global demographic projections. RESULTS: In 2022, lung cancer stood as the most frequently diagnosed cancer and the primary cause of cancer-related deaths on a global scale with approximately 2.48 million new cases and 1.8 million deaths, respectively. The incidence and mortality rates of lung cancer exhibited disparities in sex and world regions. Furthermore, incidence and mortality rates increasing as HDI increased. If the incidence and mortality rates remain stable as in 2022, the burden of lung cancer is projected to increase to 4·62 million new cases and 3·55 million deaths by 2050. CONCLUSIONS: Lung cancer is the predominant form of cancer and the foremost contributor to cancer-related mortality in 2022 with notable geographical, sex, and socioeconomic disparities.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21660 · Cited by 108,699
Bray, F., Laversanne, M., Sung, H., Ferlay, J., Siegel, R. L., Soerjomataram, I., & Jemal, A. (2024) · CA: a cancer journal for clinicians · doi:10.3322/caac.21834 · Cited by 27,064
Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening
The National Lung Screening Trial Research Team (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1102873 · Cited by 11,064
Cancer statistics for the year 2020: An overview
Ferlay, J., Colombet, M., Soerjomataram, I., Parkin, D. M., Piñeros, M., Znaor, A., & Bray, F. (2021) · International Journal of Cancer · doi:10.1002/ijc.33588 · Cited by 5,689
Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial
de Koning, H. J., van der Aalst, C. M., de Jong, P. A., Scholten, E. T., Nackaerts, K., Heuvelmans, M. A., Lammers, J.-W. J., Weenink, C., Yousaf-Khan, U., Horeweg, N., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1911793 · Cited by 3,624
Thai, A. A., Solomon, B. J., Sequist, L. V., Gainor, J. F., & Heist, R. S. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00312-3 · Cited by 2,576
Global burden of colorectal cancer in 2020 and 2040: incidence and mortality estimates from GLOBOCAN
Morgan, E., Arnold, M., Gini, A., Lorenzoni, V, Cabasag, C. J., Laversanne, M., Vignat, J., Ferlay, J., Murphy, N., & Bray, F. (2023) · Gut · doi:10.1136/gutjnl-2022-327736 · Cited by 2,429
International Statistical Classification of Diseases and Related Health Problems 10th Revision
(2013) · A Companion to the Classification of Mental Disorders · doi:10.1093/med/9780199669493.005.0005 · Cited by 2,059
Govindan, R., Page, N., Morgensztern, D., Read, W., Tierney, R., Vlahiotis, A., Spitznagel, E. L., & Piccirillo, J. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.4859 · Cited by 1,845
Screening for Lung Cancer: US Preventive Services Task Force Recommendation Statement
US Preventive Services Task Force, Krist, A. H., Davidson, K. W., Mangione, C. M., Barry, M. J., Cabana, M., Caughey, A. B., Davis, E. M., Donahue, K. E., Doubeni, C. A., et al. (2021) · JAMA · doi:10.1001/jama.2021.1117 · Cited by 1,816
Reitsma, M. B., Kendrick, P. J., Ababneh, E., Abbafati, C., Abbasi-Kangevari, M., Abdoli, A., Abedi, A., Abhilash, E. S., Abila, D. B., Aboyans, V., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)01169-7 · Cited by 1,759
The Effect of Advances in Lung-Cancer Treatment on Population Mortality
Howlader, N., Forjaz, G., Mooradian, M. J., Meza, R., Kong, C. Y., Cronin, K. A., Mariotto, A. B., Lowy, D. R., & Feuer, E. J. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1916623 · Cited by 1,712
The global burden of lung cancer: current status and future trends
Leiter, A., Veluswamy, R. R., & Wisnivesky, J. P. (2023) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-023-00798-3 · Cited by 1,477
Morgan, E., Soerjomataram, I., Rumgay, H., Coleman, H. G., Thrift, A. P., Vignat, J., Laversanne, M., Ferlay, J., & Arnold, M. (2022) · Gastroenterology · doi:10.1053/j.gastro.2022.05.054 · Cited by 1,199
Toward personalized treatment approaches for non-small-cell lung cancer
Wang, M., Herbst, R. S., & Boshoff, C. (2021) · Nature Medicine · doi:10.1038/s41591-021-01450-2 · Cited by 1,093
Ethnic and Racial Differences in the Smoking-Related Risk of Lung Cancer
Haiman, C. A., Stram, D. O., Wilkens, L. R., Pike, M. C., Kolonel, L. N., Henderson, B. E., & Le Marchand, L. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa033250 · Cited by 781
Jonas, D. E., Reuland, D. S., Reddy, S. M., Nagle, M., Clark, S. D., Weber, R. P., Enyioha, C., Malo, T. L., Brenner, A. T., Armstrong, C., et al. (2021) · JAMA · doi:10.1001/jama.2021.0377 · Cited by 633
Lung Cancer Incidence in Never Smokers
Wakelee, H. A., Chang, E. T., Gomez, S. L., Keegan, T. H., Feskanich, D., Clarke, C. A., Holmberg, L., Yong, L. C., Kolonel, L. N., Gould, M. K., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.07.2983 · Cited by 608
Lung Cancer in Never Smokers: Clinical Epidemiology and Environmental Risk Factors
Samet, J. M., Avila-Tang, E., Boffetta, P., Hannan, L. M., Olivo-Marston, S., Thun, M. J., & Rudin, C. M. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0376 · Cited by 566
Lu, T., Yang, X., Huang, Y., Zhao, M., Li, M., Ma, K., Yin, J., Zhan, C., & Wang, Q. (2019) · Cancer Management and Research · doi:10.2147/cmar.s187317 · Cited by 561
Lung Cancer Screening With Low-Dose Computed Tomography in the United States—2010 to 2015
Jemal, A., & Fedewa, S. A. (2017) · JAMA Oncology · doi:10.1001/jamaoncol.2016.6416 · Cited by 530
Advances and challenges in the treatment of lung cancer
Li, Y., Yan, B., & He, S. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115891 · Cited by 462
Global burden and trends of lung cancer incidence and mortality
Li, C., Lei, S., Ding, L., Xu, Y., Wu, X., Wang, H., Zhang, Z., Gao, T., Zhang, Y., & Li, L. (2023) · Chinese Medical Journal · doi:10.1097/cm9.0000000000002529 · Cited by 441
Self-citationMeza, R., Jeon, J., Toumazis, I., ten Haaf, K., Cao, P., Bastani, M., Han, S. S., Blom, E. F., Jonas, D. E., Feuer, E. J., et al. (2021) · JAMA · doi:10.1001/jama.2021.1077 · Cited by 320
Mikhael, P. G., Wohlwend, J., Yala, A., Karstens, L., Xiang, J., Takigami, A. K., Bourgouin, P. P., Chan, P., Mrah, S., Amayri, W., et al. (2023) · Journal of Clinical Oncology · doi:10.1200/jco.22.01345 · Cited by 288
Distribution, Risk Factors, and Temporal Trends for Lung Cancer Incidence and Mortality
Huang, J., Deng, Y., Tin, M. S., Lok, V., Ngai, C. H., Zhang, L., Lucero-Prisno, D. E., Xu, W., Zheng, Z.-J., Elcarte, E., et al. (2022) · Chest · doi:10.1016/j.chest.2021.12.655 · Cited by 247
Lung Cancer Risk Reduction After Smoking Cessation: Observations From a Prospective Cohort of Women
Ebbert, J. O., Yang, P., Vachon, C. M., Vierkant, R. A., Cerhan, J. R., Folsom, A. R., & Sellers, T. A. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.05.085 · Cited by 177
Gao, W., Wen, C. P., Wu, A., & Welch, H. G. (2022) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2021.7769 · Cited by 172
Sosa, E., D’Souza-Rushton, G. C., Akhtar, A., Sur, M., Love, K., Duffels, J., Raz, D. J., Kim, J. Y., Sun, V. C.-Y., & Erhunmwunsee, L. (2021) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21671 · Cited by 167
Vaccarella, S., Georges, D., Bray, F., Ginsburg, O., Charvat, H., Martikainen, P., Brønnum-Hansen, H., Deboosere, P., Bopp, M., Leinsalu, M., et al. (2022) · The Lancet Regional Health - Europe · doi:10.1016/j.lanepe.2022.100551 · Cited by 167
Gender-specific aspects of epidemiology, molecular genetics and outcome: lung cancer
Mederos, N., Friedlaender, A., Peters, S., & Addeo, A. (2020) · ESMO Open · doi:10.1136/esmoopen-2020-000796 · Cited by 158
Radon and Lung Cancer in the American Cancer Society Cohort
Turner, M. C., Krewski, D. R., Chen, Y., Pope, C. A., Gapstur, S. M., & Thun, M. J. (2011) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-10-1153 · Cited by 149
The Effect of Age at Smoking Initiation on Lung Cancer Risk
Hegmann, K. T., Fraser, A. M., Keaney, R. P., Moser, S. E., Nilasena, D. S., Sedlars, M., Higham-Gren, L., & Lyon, J. L. (1993) · Epidemiology · doi:10.1097/00001648-199309000-00010 · Cited by 144
Racial and Ethnic Differences in the Epidemiology and Genomics of Lung Cancer
Schabath, M. B., Cress, W. D., & Muñoz-Antonia, T. (2016) · Cancer Control · doi:10.1177/107327481602300405 · Cited by 140
Luo, Y., Luo, L., Wampfler, J. A., Wang, Y., Liu, D., Chen, Y.-M., Adjei, A. A., Midthun, D. E., & Yang, P. (2019) · The Lancet Oncology · doi:10.1016/s1470-2045(19)30329-8 · Cited by 114
Bruce, N., Dherani, M., Liu, R., Hosgood, H. D., Sapkota, A., Smith, K. R., Straif, K., Lan, Q., & Pope, D. P. (2015) · Thorax · doi:10.1136/thoraxjnl-2014-206625 · Cited by 107
Zhou, B., Zang, R., Zhang, M., Song, P., Liu, L., Bie, F., Peng, Y., Bai, G., Huai, Q., Li, Y., et al. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2022.103951 · Cited by 93
Liao, W., Coupland, C. A. C., Burchardt, J., Baldwin, D., Gleeson, F. V., Baldwin, D., Batchkala, G., Buchanan, J. P., Burchardt, J., Chakraborty, R., et al. (2023) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(23)00050-4 · Cited by 84
Bi, J., Tuo, J., Xiao, Y., Tang, D., Zhou, X., Jiang, Y., Ji, X., Tan, Y., Yuan, H., & Xiang, Y. (2023) · Thoracic Cancer · doi:10.1111/1759-7714.15170 · Cited by 75
The barriers to initiating lung cancer care in low-and middle-income countries
Lubuzo, B., Ginindza, T. G., & Hlongwana, K. W. (2020) · Pan African Medical Journal · doi:10.11604/pamj.2020.35.38.17333 · Cited by 70
Singh, D., Vaccarella, S., Gini, A., Silva, N. D. P., Steliarova‐Foucher, E., & Bray, F. (2022) · International Journal of Cancer · doi:10.1002/ijc.33948 · Cited by 66
Socio-economic status and lung cancer risk including histologic subtyping—A longitudinal study
Ekberg-Aronsson, M., Nilsson, P. M., Nilsson, J.-Å., Pehrsson, K., & Löfdahl, C. (2005) · Lung Cancer · doi:10.1016/j.lungcan.2005.08.014 · Cited by 49
The first surgeon general's report on smoking and health: The 50th anniversary
Brawley, O. W., Glynn, T. J., Khuri, F. R., Wender, R. C., & Seffrin, J. R. (2013) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21210 · Cited by 48
Immunotherapy and targeted therapy for lung cancer: Current status and future perspectives
Zulfiqar, B., Farooq, A. V., Kanwal, S., & Asghar, K. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1035171 · Cited by 44
Kim, Y. W., Kang, H.-R., Kwon, B. S., Lim, S. Y., Lee, Y. J., Park, J. S., Cho, Y., Yoon, H. I., Lee, K. W., Lee, J. H., et al. (2020) · European Respiratory Journal · doi:10.1183/13993003.00177-2020 · Cited by 38
Rurality, Stage-Stratified Use of Treatment Modalities, and Survival of Non-small Cell Lung Cancer
Ray, M. A., Faris, N. R., Derrick, A., Smeltzer, M. P., & Osarogiagbon, R. U. (2020) · CHEST Journal · doi:10.1016/j.chest.2020.04.042 · Cited by 35
Inferring lung cancer risk factor patterns through joint Bayesian spatio-temporal analysis
Cramb, S. M., Baade, P. D., White, N. M., et al. (2015) · Cancer Epidemiology · doi:10.1016/j.canep.2015.03.001 · Cited by 23
Lung Cancer Management in Low and Middle-Income Countries
Jiwnani, S., Penumadu, P., Ashok, A., & Pramesh, C. S. (2022) · Thoracic Surgery Clinics · doi:10.1016/j.thorsurg.2022.04.005 · Cited by 19
A novel autoantibody test for the detection of pre-neoplastic lung lesions
Lowe, F., Shen, W., Zu, J., Li, J., Wang, H., Zhang, X., & Zhong, L. (2014) · Molecular Cancer · doi:10.1186/1476-4598-13-78 · Cited by 16
Research works printed but not linked: 5
- Duma, 2023, Disparities in lung cancer, J. Natl. Med. Assoc., 115
- Boffetta, 2001, Incidence of lung cancer in a large cohort of non-smoking men from Sweden, Int. J. Cancer, 94, 591, 10.1002/ijc.1507 · doi:10.1002/ijc.1507
- Bao, 2024, LDCT screening results among eligible and ineligible screening candidates in preventive health check-ups population: a real world study in West China, Sci. Rep., 14, 4848, 10.1038/s41598-024-55475-x · DOI
- Wu, 2023, Optimizing lung cancer screening with risk prediction: current challenges and the emerging role of biomarkers, J. Clin. Oncol.: Off. J. Am. Soc. Clin. Oncol., 41, 4341, 10.1200/JCO.23.01060 · doi:10.1200/jco.23.01060
- Pinsky, 2021, Potential disparities by sex and race or ethnicity in lung cancer screening eligibility rates, Chest, 160, 341, 10.1016/j.chest.2021.01.070 · doi:10.1016/j.chest.2021.01.070
Cited by
Elkefi, S., Wu, P., Sabra, R., Feiner, S., Chen, L., Hembroff, G., & Matthews, A. K. (2025) · npj Digital Medicine · doi:10.1038/s41746-025-01913-7 · Cited by 8
Zheng, Q., Liu, Y., Li, T., Zhang, X., Geng, Y., Chen, Z., Zhou, J., Fan, W., Wang, Y., Zhang, L., et al. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1871582
Self-citation
Metadata
- Authors
- Zhou, J., Xu, Y., Liu, J., Feng, L., Yu, J., & Chen, D.
- Venue
- Cancer Epidemiology
- Publisher
- Elsevier BV
- Published
- 2024-12
- Volume
- 93
- Pages
- 102693
- ISSN
- 1877-7821 (ISSN-L)
- OpenAlex
- W4404337253
- Cited by
- 389
- References
- 49
- FWCI
- 59.55
- Type
- journal article
- Language
- en
- Open access
- hybrid
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by/4.0/ (vor)
- Funders
- National Natural Science Foundation of China (8203000516)
- Shandong Province Natural Science Foundation (ZR2023ZD26)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.